Home > Executive Committee

Executive Committee

Elected for the period 2020-2022

President – Mr. Sai D. Prasad, Bharat Biotech International Ltd., India
Sai Prasad has progressive experience in management, from basic science research, good manufacturing practice, good laboratory practice, technical operations, to quality management, associated with Bharat Biotech since 2004. In his current role as the President of Quality Operations, he oversees all aspects of quality management including quality assurance, quality control, and quality management systems, aiming to translate innovation, novel R&D and product development by the company into products with global access. Previously he was the product development lead for several vaccines and biologics. He received his degree in biochemistry from the University of Wisconsin (USA) and his M.B.A in Finance and Marketing from the University of Iowa (USA).
Vice-President – Mr. Patrick Tippoo, Biovac Institute, South Africa
Mr. Tippoo has been with Biovac since its inception in 2003, serving as Head of Science & Innovation, The Biovac Institute. He heads product and business development and is responsible for fostering strategic alliances as well as local and international partnering opportunities with respect to product development and inbound and outbound technology transfer projects.
Treasurer – Mr. Fernando Lobos, Sinergium Biotech, Argentina
Mr. Lobos is Engineer and MBA with 20-years’ professional experience in management, focused on new business development, engineering, start-up and operations of pharmaceutical companies. He has been working in vaccine companies for over 12 years. He holds a engineering degree from University of Buenos Aires.
Member - Ms. Lingjiang Yang, CNBG, China
Ms. Lingjiang Yang is Manager of International Business and Cooperation of Chengdu Institute of Biological Products Co., Ltd. (CDIBP), an affiliate of CNBG, the China’s largest state-owned biological company and the first WHO-prequalified Chinese vaccine manufacturer. She is responsible for all international cooperation development and management, as well as taking care the international marketing. Her experience as the project coordinator of the WHO prequalification project of live Japanese encephalitis vaccine has given her insights of global vaccine industry. She has a degree in biotechnology.
Member – Ms. Weidan Huang, Xiamen Innovax Biotech Co., Ltd, China
Ms. Huang joined Innovax in 2010. She has 9 years of experience in the vaccine industry and hasparticipated in all stages of HPV vaccine development. Currently, Ms. Huang is Assistant to General Manager, Xiamen INNOVAX Biotech and also the chief coordinator of the HPV vaccine product program and leads the WHO prequalification projects at Innovax. She holds a master degree in Biochemistry and Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute of Biological Sciences, Chinese Academy of Sciences.
Member – Mr. Adriansjah Azhari, Biofarma, Indonesia
Mr. Azhari joined Biofarma in 1989 and has vast experience in biotechnology, Quality Management including Good Manufacturing Practices. He is a pharmacist and holds a Master’s degree in Operations Management. He is currently a member of the Board of Executives of Biofarma as Senior Executive Vice President overseeing Research and Development activities. His previous appointments in the company were Head of Business Planning and Strategy, Head of Quality Assurance/responsible pharmacist, Head of bacterial vaccines production and Head of formulation/filling/packaging.
Member – Mr. Tiago Rocca, BD , Butantan Institute, Brazil
Mr. Rocca serves as Strategic Partnerships & Business Development Manager at Instituto Butantan. Rocca has been working at Butantan for over 12 years and has assumed responsibilities in several other areas related to vaccines and biopharmaceuticals production, Technology Transfer, Validation, Quality Assurance and Compliance. Pharmacist, Health Law specialist from the Public Health School of University of São Paulo, he completed the course on GMP for Influenza Vaccines Manufacturers at Biomanufacturing Training and Educational Center (BTEC), North Caroline State University.
GAVI Board Member for DCVMN - Mr. Sai D. Prasad
Sai Prasad has progressive experience in management, from basic science research, good manufacturing practice, good laboratory practice, technical operations, to quality management, associated with Bharat Biotech since 2004. In his current role as the President of Quality Operations, he oversees all aspects of quality management including quality assurance, quality control, and quality management systems, aiming to translate innovation, novel R&D and product development by the company into products with global access. Previously he was the product development lead for several vaccines and biologics. He received his degree in biochemistry from the University of Wisconsin (USA) and his M.B.A in Finance and Marketing from the University of Iowa (USA).
GAVI Board Alternate & GAVI PPC representative for DCVMN - Ms. Mahima Datla (non-voting)
Mahima Datla directly oversees strategic operations within Biological E organization and leads the work related to public policy. She has been working with BE for the past 17 years and has served in various capacities across a diverse range of functions. Apart from Biological E, Mahima has served on the steering committee of DCVMN as well as GAVI Board, and as member of CII National Biotech committees.
Executive Secretary - Dr. Sonia R Pagliusi (non-voting)
Dr. Pagliusi is the Executive Secretary of DCVMN International since 2011 and is deeply committed to improving healthcare globally. She has over 25 years of professional experience, with a balanced track record in both private and public sectors, working with leading multinational pharmaceutical and biotechnology industries, in research and development and with WHO in vaccine quality assessment and introduction. She holds degrees in Biomedical Sciences from Paulista Medical School, Brazil, Biochemistry Diplom from Free University Berlin, a PhD in Molecular Biology from Heidelberg University and a Public Health Management degree from Geneva University.

New Committee Members Announcement

As you would be aware the Developing Countries Vaccine Manufacturers Network (DCVMN) held elections for Executive Committee members and put forward their votes for new committee members on 22nd October 2019, at the 20th AGM in Rio, Brazil.

We are very pleased to welcome new incoming committee members Ms. Weidan Huang, Mr. Tiago Rocca and Mr. Adriansjah Azhari, joining Ms. Yang, Mr Prasad, Mr. Tippoo and Mr. Lobos.

All committee roles are reviewed and, to support professional development within the committee, these roles are reallocated by vote. For your information, according to the article 3.9 and of the bylaws/internal rules, the new elected Executive Committee 2020-2022 is composed as follows:

  • Mr. Sai Prasad, President
  • Mr. Patrick Tippoo, Vice President
  • Mr. Tiago Rocca, Executive Committee member
  • Mr. Adriansjah Azhari, Executive Committee member
  • Mr. Fernando Lobos, Executive Committee member
  • Ms. Lingjiang Yang, Executive Committee member:
  • Ms. Weidan (Wendy) Huang: Executive Committee member.

We thank all the elected members for their interest and generous availability to voluntarily serve the association.

MEETINGS MINUTES (Members only - Please log in to access)

Partners: